UOB TP to 12.40.

Nice good analysis. Very concise and precise to the core business revenue and net profit growth.

Ask ourselves, even new vaccine out.. are we dare enough to inject non-affected healthy body with this unverified, not proven vaccine dose? Are there any med to long term side effects repercussion after the injection? Will it cause any uninvited sickness & health issues after the injection? What is the effectiveness & success rate of this new vaccine injection into healthy human body, etc.

With Covid19 virus keep on mutating to stronger different type of strains, can vaccine able to cope the rapid changing type of mutated strain? Do we have to keep on injecting multiple of different vaccine doses yearly like those common seasonal influenza flu like Influenza A, B etc... to protect ourselves yearly? how effective it is?

There are too many questions and unknown scenario, that even health experts cant provide an convince supportive scientific data and figure. This Covid19 pandemic is not that easily eliminate even a new vaccine is out by mid 2021. I strongly believe all PPE equipment like glove supply still need in larger volume till 2022 and forward.

Ask ourselves, even new vaccine out.. are we dare enough to inject non-affected healthy body with this unverified, not proven vaccine dose? Are there any med to long term side effects repercussion after the injection? Will it cause any uninvited sickness & health issues after the injection? What is the effectiveness & success rate of this new vaccine injection into healthy human body, etc.

With Covid19 virus keep on mutating to stronger different type of strains, can vaccine able to cope the rapid changing type of mutated strain? Do we have to keep on injecting multiple of different vaccine doses yearly like those common seasonal influenza flu like Influenza A, B etc... to protect ourselves yearly? how effective it is?

There are too many questions and unknown scenario, that even health experts cant provide an convince supportive scientific data and figure. This Covid19 pandemic is not that easily eliminate even a new vaccine is out by mid 2021. I strongly believe all PPE equipment like glove supply still need in larger volume till 2022 and forward.

Ask ourselves, even new vaccine out.. are we dare enough to inject non-affected healthy body with this unverified, not proven vaccine dose? Are there any med to long term side effects repercussion after the injection? Will it cause any uninvited sickness & health issues after the injection? What is the effectiveness & success rate of this new vaccine injection into healthy human body, etc.

With Covid19 virus keep on mutating to stronger different type of strains, can vaccine able to cope the rapid changing type of mutated strain? Do we have to keep on injecting multiple of different vaccine doses yearly like those common seasonal influenza flu like Influenza A, B etc... to protect ourselves yearly? how effective it is?

There are too many questions and unknown scenario, that even health experts cant provide an convince supportive scientific data and figure, this Covid19 pandemic is not that easily eliminate even a new vaccine is out by mid 2021. I strongly believe all PPE equipment like glove supply still need in larger volume till 2022 and forward.

fund mgr and IB already scare off all the small retailer last round to collect their low price share holding.. now IB and fund mgr want to make money now.. let glove counters price appreciation show it potential, up to the moon .. the beast is out and roar louder now.
for those who still dont know how to value & appreciate glove stocks.. still ignorant of dont understd the fundamental and coming next 6 Qtrs earning result.

Supermax still cheap now.. Mega sale to hit RM18.. with forward PE 20.. bigger room to grow further up.. 100% to grow further..

its still cheap for Supermx even hit 9.30+, still have RM9.00 that 100% potential to grow further

Supermx is still very undervalued now among top 4 glove.. actually its earning way better than Kossan and others as well due to OBM as what KYY share.. think about that!

Today, CGS-CIMB Securities Sdn Bhd analyst Walter Aw wrote in a note that the research firm stays overweight on the rubber glove sector.

"In our view, glove stocks remain attractive as key beneficiaries of strong global glove demand from Covid-19. Based on our channel checks, glove makers' order book visibility remains strong (six to eight months) with expectations of further hikes in glove ASPs (average selling prices)," Aw said.
Glove makers' share prices have risen due to a resurgence of global Covid-19 infections.

It was reported that new US Covid-19 cases rose by nearly 50,000 yesterday, according to a Reuters tally, marking the biggest one-day spike since the start of the pandemic.

It was reported that the record follows a warning by the government's top infectious disease expert that the number could soon double to 100,000 cases a day if Americans do not come together to take steps necessary to halt the virus' resurgent spread, such as wearing masks when unable to practise social distancing.

"In the first week of June, the US added about 22,000 new [Covid-19] cases each day. But as the month progressed, hotspots began to emerge across the Sun Belt. In the last seven days of June, daily new infections almost doubled to 42,000 nationally.

"Brazil is the only other country to report more than 50,000 new cases in one day. The US reported at least 49,286 cases on Tuesday," Reuters reported

Actually CIMB target price 9.80 is very conservative. If net earning profit RM250mil to RM300mil , it EPS shoot up to 20sen to 25sen this Quarter earning, that huge price appreciation. What KYY mention of target price RM18 is not too aggressive to be precise, is consider moderate to low assumption. Imagine every mth to mth ASP price up 10% till mid to end 2021.. That a huge opportunity if look for mid term gain.

Well said glovehaircut.. thanks for sharing the consolidated insight valuable inputs. Thanks bro!

The lion is awaken.. the beast is out and roar louder. Where all the sin kar lan.. all the naysayers?..

the Lion is awaken, let it out and roar louder.. showing its true color.

Ask yourself, what is the stock selection that can buy, most benefit on this Covid19 pandemic beside gloves sector? Do share if has better stocks selection that coming fews Qtrs make money.

In God we trust, but we do need to practise scientific and health experts advise. Wear mask during outdoor, practice wash hand hygiene and social distance to reduce infection and mortality rate.
We need to work together to cut the infection chain effect. If we still sturborn, ego and ignorance.. The effects its not only affect yourself, u may infect your families members, parents, children and whole communities as well. Break the infection chain effect by practice these 3 simple habits.. If not many peoples will die, local businesses and unemployment and economic goes south and dead spiral down in many months.

Dont over rely hope on vaccine. Till now no scientific proven how good is the vaccine cure rate effectiveness as of when can it ready to be test on healthy human being without any side effects? A healthy people, will they mentallly prepare to be inject with this new vaccine and be the tester specimen? Any long term side effects?

There too many questions arise with less to no proven convince answers.. Better still practise wear mask, wash hands frequently and social distance for this new norm world for now

Luckily enough we Msia glove sector provide a high good quality world class glove that protect and help health experts in to fight this Covid19 pandemic.

for those dont know glove fundamental, pls keep quiet.. this show how silly and ignorance of you of no research and study the fundamental core glove business. All IB & foreign analysts stated clearly glove sector has huge potential to growth till end of 2021 in term of shortage of supply vs raising demand.

Resurgence of 2nd wave, ASP & spot price shoot up high mth to mth...great opportunity to collect now before the plane fly high.

Supermax Plant #12, additional new capacity of 2.2 billion gloves p.a would be running in CY3Q2020 & fully commissioned by CY4Q2020.

Do not underestimate Harta, coming Qtr result will be very powerful.. easily can hit close to Topglove result >Rm300mil net profit.. you will be surprise by it in coming Qtr result report!

Topglove analyst TP:

AMInvest RM20.06
BIMB RM20.50
RHB RM20.50
MACQUARIE RM20.50
UOB RM21.90
MAYBANK RM21.90
AFFIN RM22.40
JF APEX RM22.41
CREDIT SUSIE RM23.00
JP MORGAN RM 23.30
HONG LEONG RM23.91
CIMB RM25
KENANGA RM25

Those who dont know how to value glove sector for future price, pls dont said anything.. fyi .. next 4 forward Qtr earning result until Q1'21 is way undervalued, worth less than PE 20. Daily fluctuation doesnt represent anything.. other SGX glove stock stay so firm & glove shortage is real.. 2nd wave infection is good for glove as spot order sales will shoot up, 2 to 3x ASP price higher.. already stated clear by Topglove latest Qtr result, up 5% ASP price help boost from RM115mil to RM350mil.. almost 3x times.. imagine if ASP June'20 onward 15% ASP up.. how much was it?

Pls rethink 1st, 2nd wave infection...is that good news for glove maker counter? Higher demand, better ASP price, more spot order price, further increase to 3 to 5 times soon. Why blindly sell without think 1st? Supermax, Topglove owner mentioned the sales order last 1.5year to 2 years. With shortage glove, isn't that push up the ASP price higher?

comfort, ruberex also up,, why worry on Supermx... those sell will cry in coming weeks

last call for Supermx to buy.. coming Qtr in July will be more than EPS 10sen+.

Whole glove core business is good, demand higher than supply, margin improve, sales order till 400 days waiting time once order, ASP increase to 15% vs 5% reported Qtr result, potential can gain 3x times net profit in coming Jun to Aug results, ad hoc spot order boost 3x time ASP prices, factory utilisation 95% vs 85% last Qtr, more lean and improve output efficiency, USD vs Rm currency improve, raw cost materials latexx + nitrile reduce, operation cost improved. Sales order spike increase till mid June 2021 (400days). Glove output now 78.4bil increase to 84.8 bil glove by end CY2020 per annum.
US starting to show symptom of 2nd wave infection increase rate, expected propagate to other major cities in coming 2 to 3 weeks.
I really dont know why glove sector not good, especially Topglove and Supermax...

Think wisely, dotn just complain without facts and figures.

Topglove Qtr result is outstanding, ASP price only increase 5% QoQ can hit RM350mil.. Imagine next Q4'20 ASP hit 15%, month on month increase, that will be 3x times of today earning

3QFY20 performance highlights:
a) Higher utilisation rate resulting in greater efficiency and economies of scale and continuous improvement in quality.
b) Strong growth in sales quantity of 25% QoQ and 24% YoY.
c) Improvement in ASP of 5% QoQ and 9% YoY.
d) USD strengthened by 5% for both QoQ and YoY.

Raw Material Price:
a) Latex price decreased by 1% vs 2QFY20, and 4% vs 3QFY19.
b) Nitrile price decreased by 10% vs 2QFY20, and 14% vs 3QFY19.

Continue strong performance in coming quarters underpin by exceptional strong demand with
longer lead time to around 400 days

Topglove Qtr result is outstanding, ASP price only increase 5% QoQ can hit RM350mil.. Imagine next Q4'20 ASP hit 15%, month on month increase, that will be 3x times of today earning

3QFY20 performance highlights:
a) Higher utilisation rate resulting in greater efficiency and economies of scale and continuous improvement in quality.
b) Strong growth in sales quantity of 25% QoQ and 24% YoY.
c) Improvement in ASP of 5% QoQ and 9% YoY.
d) USD strengthened by 5% for both QoQ and YoY.

Raw Material Price:
a) Latex price decreased by 1% vs 2QFY20, and 4% vs 3QFY19.
b) Nitrile price decreased by 10% vs 2QFY20, and 14% vs 3QFY19.

Continue strong performance in coming quarters underpin by exceptional strong demand with
longer lead time to around 400 days

Texas, US start the 1st state with 2nd wave infection.. 3rd straight day of record of hospitalization

https://www.cnbc.com/2020/06/10/texas-reports-a-third-straight-day-of-record-coronavirus-hospitalizations.html

https://www.cnbc.com/2020/06/10/texas-reports-a-third-straight-day-of-record-coronavirus-hospitalizations.html

2nd wave infection starting in Texas, US now after city reopen.. why fear?

those who sell half day to 8.25, sure regret and crying now.. back to 8.87 now

Credit suite raise Topglove TP to RM23.00.

Kossan Rubber Industries - CIMB new target after, higher ASPs on the cards (Upgrade in Add with a higher TP of RM11.50). CIMB analyst turn more positive on Kossan post its conference call today 3th June 2020, given its ASP hikes and higher output to cater to the increase in glove demand

Kossan Rubber Industries - CIMB new target after, higher ASPs on the cards (Upgrade in Add with a higher TP of RM11.50). CIMB analyst turn more positive on Kossan post its conference call today 3th June 2020, given its ASP hikes and higher output to cater to the increase in glove demand

Kossan Rubber Industries - CIMB new target after, higher ASPs on the cards (Upgrade in Add with a higher TP of RM11.50). CIMB analyst turn more positive on Kossan post its conference call today 3th June 2020, given its ASP hikes and higher output to cater to the increase in glove demand.

on the bright side, investor buying now is used their own money, not margin.. genuine investor in the glove market now.

Be caution, CIMB today trigger margin restriction, effective immediately today same as RHB. Now Maybank, RHB & CIMB affected.

Be caution, CIMB today trigger margin restriction, effective immediately today same as RHB. Now Maybank, RHB & CIMB affected.

Supermax Mr Ng Director used own money buy 200lots bought at 7.70 to 8.00 on 29th May. That's rm1.5 to rm1.6mil bought. Do u believe Director buy at this level for what?

bonus issue coming for TG, Supermax, Harta & Kossan announcement soon...

Supermax is OBM, way better than Topglove & Harta in term of ASP price. Opportunity is big. Raise Target Price for Supermax from Rm12.00 to Rm14.00 is reasonable... any price drop, opportunity to collect. FYI is ASP price increase 300% to 500% before pandemic for Supermax.

fyi, TG SGD 6.40 now, mean Topglove Msia is RM19.84.. Big opportunity in Msia TG..

It outrageous, the infection new case ystdy was only 6.02mil case last Friday, today shoot up to 6.25mil, an increase of 125k new cases per day, mainly increase on US, Brazil, Russia, India, Peru. Dont know how it goes in coming mths... seem like the number keep on raising after more countries open from lock down.

FYI. SGP Topglove hit $6.00 now, that RM18.60 convert to Msia Topglove. Potential for Msia Topglove to goes to hit limit up today to catch up. Can hit beyond RM20 if Covid19 drags longer & 2nd wave explode again, Topglove will reach Rm25 to Rm30.00

it outrageous, the infection new case ystdy was only 6.02mil case last Friday, today shoot up to 6.25mil, an increase of 125k new cases per day, mainly increase on US, Brazil, Russia, India, Peru. Dont know how it goes in coming mths... seem like the number keep on raising after more countries open from lock down.

Petramaises: topglove detention list is very old story, way before July 2013. No impact. Worry is will comfort glove sales hold or not later this May onward for US market? Will Europe authority follow the same path as US?
Just be caution.

Government contract only consist 20% revenue, mainly on the Immigration & JPJ providing service, whereas 80% revenue come from commercial online auto insurance renewal, foreign worker insurance renewal and job placement services worker. Potential Msia government to bring back GST system, reintroduce back.. sure bring another big revenue to MYEG this year too.

Management already expand their services to oversea - Indonesia, Philippines and Bangladesh, taking action to reduce their risk depending on single government. Oversea expansion is successfully launched online insurance portal in Philippines (Jan19), enters into an investment agreement with Jingle Magic (Beijing) Technology in the development of virtual reality, augmented reality and artificial intelligence-based education equipment and software (Apr19), subscription of PT Cartenz share though Myeg Indonesia (Jul19) then launch tax monitoring system in Indonesia (Jan20) and launches first phase of digital e-Government services in partnership with Land Bank of the Philippines (Nov19).

Future expansion is bright, plus the 1st earning come from Philipine e-government revenue & next Qtr VAT revenue from Indonesia, I believe investor smart enough to measure and calculate on its growth this whole year 2020.

This extension to 30th June is good news! Expected MyEG will continue get the tender since it is establish, well received by rakyat all the while. Investor should look further, look on bigger picture. Philippines e-government earning is out this Jan-Mar Qtr result as well. MyEg owner + EPF + KWSP keep on buying.. today is a big opportunity to collect before is shoot up after result out.

It confirm, 2nd wave lockdown in China, affect 100mil people. This open, lock down back and forth will occur from time to time till effective vaccine is develop for mass volume usage availability which take the fastest at least 12 to 18mths ready. That's still a long way to go.

https://www.google.com/amp/s/nationalpost.com/news/world/over-100-million-people-in-chinas-northeast-region-are-back-under-lockdown/amp


Fyi, Kossan this Qtr Q120 still have raise the ASP price yet, in month of May Topglove mgmt told ASP price raise to 5% to 10% and then Supermax mgmt stated up 10% to 15% starting June mth..so it very obvious all gloves ASP price will shoot much higher in Q220 and get even much higher in Q320 moving forward.
Bigger opportunities for those glove counters which notmup yet and still undervalued for now.

It confirm, 2nd wave lockdown in China, affect 100mil people. This open, lock down back and forth will occur from time to time till effective vaccine is develop for mass volume usage availability which take the fastest at least 12 to 18mths ready. That's still a long way to go.

https://www.google.com/amp/s/nationalpost.com/news/world/over-100-million-people-in-chinas-northeast-region-are-back-under-lockdown/amp